NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Briacell Therapeutics Corp. Common Shares Share Price Chart

O H L

Briacell Therapeutics Corp. Common Shares Performance Overview

Days Range
$4.06Low
$4.16High

Markets Today

Previous Close$4.22
Open$4.13
Volume69,282
Day's Range$4.06 - $4.16
52W Range$2.60 - $14.68
Market Cap$30.97 M

Historical Performance

1M Returns+19.55
3M Returns+45.52
6M Returns-2.09
1Y Returns-53.52
5Y Returns-99.64
10Y ReturnsNA

Briacell Therapeutics Corp. Common Shares Fundamentals

Market Cap$30.97 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTMN/A
EPS TTM$-17.14
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-27.10 M
Profit MarginN/A
Market Cap$30.97 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTMN/A
EPS TTM$-17.14
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-27.10 M
Profit MarginN/A

Briacell Therapeutics Corp. Common Shares Profit & Loss

Jan 2025Apr 2025Jul 2025Oct 2025Jan 2026Apr 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$7.17 M-$6.33 M-$8.55 M-$8.32 M-$7.53 M-$7.62 M
EBITDA -$7.14 M-$6.30 M-$8.53 M-$8.30 M-$7.50 M-$7.59 M
Interest Expense $0$0$0$0$0$0
Depreciation $26.66 K$26.66 K$26.66 K$26.66 K$26.66 K$33.01 K
Income Before Tax -$6.34 M-$6.22 M-$8.16 M-$8.28 M-$7.30 M-$7.24 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$6.34 M-$6.22 M-$8.16 M-$8.28 M-$7.30 M-$7.24 M
Net Profit Margin ------

Briacell Therapeutics Corp. Common Shares Financials Balance Sheet In USD

Jan 2025Apr 2025Jul 2025Oct 2025Jan 2026Apr 2026
Share Capital $85.45 M$94.02 M$101.74 M$101.74 M$117.12 M$117.12 M
Reserve & Surplus -$97.68 M-$103.80 M-$111.89 M-$120.09 M-$127.31 M-$134.48 M
Non-Current Liabilities $905.84 K$730.01 K$337.67 K$406.87 K$195.10 K$71.85 K
Current Liabilities $5.23 M$4.33 M$3.98 M$3.32 M$3.19 M$3.59 M
Total Liabilities $6.14 M$5.06 M$4.32 M$3.72 M$3.38 M$3.66 M
Fixed Assets $534.66 K$508.00 K$481.34 K$454.69 K$428.03 K$522.07 K
Current Assets $7.16 M$14.79 M$19.93 M$11.35 M$32.18 M$25.39 M
Total Assets $9.36 M$17.00 M$21.65 M$13.08 M$33.59 M$27.07 M

Briacell Therapeutics Corp. Common Shares Cash Flow

Jan 2025Apr 2025Jul 2025Oct 2025Jan 2026Apr 2026
Net Income -$6.34 M-$6.22 M-$8.16 M-$8.28 M-$7.30 M-$7.24 M
Operating Cash Flow -$5.92 M-$7.16 M-$8.13 M-$7.70 M-$7.97 M-$7.02 M
Investing Cash Flow -$75.00 K-$105.00 K-$7.39 M-$75.00 K$7.28 M-$16.00 M
Financing Cash Flow $5.22 M$14.71 M$13.56 M$0$27.87 M$0
Change in Cash -$778.61 K$7.45 M-$1.97 M-$7.78 M$27.19 M-$23.02 M

Briacell Therapeutics Corp. Common Shares Return Calculator

The Briacell Therapeutics Corp. Common Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$35
Invested Amount$10,000
Est. Returns$-9,965
Invest in USA Stock Today

About Briacell Therapeutics Corp. Common Shares

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

FAQs

Briacell Therapeutics Corp. Common Shares (BCTX) share price as of September 18, 2026 is $4.09. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Briacell Therapeutics Corp. Common Shares (BCTX) Share by opening an international trading account with Angel One.
Purchasing Briacell Therapeutics Corp. Common Shares (BCTX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Briacell Therapeutics Corp. Common Shares (BCTX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Briacell Therapeutics Corp. Common Shares (BCTX) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Briacell Therapeutics Corp. Common Shares on September 18, 2026, is $30.97 M.
Briacell Therapeutics Corp. Common Shares operates in the null sector, specifically in the null industry.
In order to invest in Briacell Therapeutics Corp. Common Shares (BCTX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91